Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Global Endovenous Ablation Devices Market: About this market
Endovenous ablation devices are used to treat chronic venous insufficiency (CVI) with varicose veins. These devices are designed to perform minimally invasive procedures. endovenous ablation devices market analysis considers sales from the endovenous laser ablation therapy (EVLT) devices, radiofrequency ablation (RFA) devices, and non-thermal non-tumescent (NTNT) devices segments. Our analysis also considers the sales of endovenous ablation devices in Asia, Europe, North America, and ROW. In 2018, the EVLT segment held the highest market share. This trend is expected to remain prevalent over the forecast period. Factors such as the high success rate of EVLT devices compared with others and their ability to perform minimally invasive procedures without spinal or general anesthesia are helping the EVLT segment in maintaining its leading market position. Also, our global endovenous ablation devices report has observed market growth factors such as the increasing prevalence of CVI, growing demand for MI endovenous ablation procedures, and technological advances in endovascular ablation devices. However, challenges such as high cost coupled with unfavorable reimbursement policies, limitations and complications associated with endovenous ablation techniques, and shortage of skilled vascular surgeons may hamper the growth of the endovenous ablation devices industry over the forecast period.
Global Endovenous Ablation Devices Market: Overview
Increasing prevalence of CVI
One of the high risk factors for CVI is aging. Therefore, the growing geriatric population will increase the incidence of CVI. Other risk factors include obesity, smoking, and pregnancy, which are also prevalent. Moreover, CVI is a progressive medical condition, which worsens with time. As a result, the need for effective treatment of CVI is increasing. Therefore, the sales of endovenous ablation devices have been increasing, which will lead to the expansion of the global endovenous ablation devices market. The market will grow at a CAGR of almost 4% during the forecast period.
Emergence of endovenous steam ablation (EVSA) as an alternative to EVLA and RFA
The EVSA method has better patient tolerance compared with EVLA and RFA. This factor is attributed to the minute and flexible catheter of EVSA compared with the stiff glass fibers of EVLA and RFA. EVSA catheters can easily be inserted into veins without inflicting pain on the patient. Therefore, the emergence of EVSA as an alternative to EVLA and RFA will have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global endovenous ablation devices market during the forecast period 2019-2023, click here.
Competitive Landscape
With the presence of a few major players, the global endovenous ablation devices market is concentrated. robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of several leading endovenous ablation devices manufacturers, which include AngioDynamics Inc., Medtronic Plc, Sciton Inc., Teleflex Inc., and Venclose Inc.
Also, the endovenous ablation devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Endovenous ablation devices are used to treat chronic venous insufficiency (CVI) with varicose veins. These devices are designed to perform minimally invasive procedures. endovenous ablation devices market analysis considers sales from the endovenous laser ablation therapy (EVLT) devices, radiofrequency ablation (RFA) devices, and non-thermal non-tumescent (NTNT) devices segments. Our analysis also considers the sales of endovenous ablation devices in Asia, Europe, North America, and ROW. In 2018, the EVLT segment held the highest market share. This trend is expected to remain prevalent over the forecast period. Factors such as the high success rate of EVLT devices compared with others and their ability to perform minimally invasive procedures without spinal or general anesthesia are helping the EVLT segment in maintaining its leading market position. Also, our global endovenous ablation devices report has observed market growth factors such as the increasing prevalence of CVI, growing demand for MI endovenous ablation procedures, and technological advances in endovascular ablation devices. However, challenges such as high cost coupled with unfavorable reimbursement policies, limitations and complications associated with endovenous ablation techniques, and shortage of skilled vascular surgeons may hamper the growth of the endovenous ablation devices industry over the forecast period.
Global Endovenous Ablation Devices Market: Overview
Increasing prevalence of CVI
One of the high risk factors for CVI is aging. Therefore, the growing geriatric population will increase the incidence of CVI. Other risk factors include obesity, smoking, and pregnancy, which are also prevalent. Moreover, CVI is a progressive medical condition, which worsens with time. As a result, the need for effective treatment of CVI is increasing. Therefore, the sales of endovenous ablation devices have been increasing, which will lead to the expansion of the global endovenous ablation devices market. The market will grow at a CAGR of almost 4% during the forecast period.
Emergence of endovenous steam ablation (EVSA) as an alternative to EVLA and RFA
The EVSA method has better patient tolerance compared with EVLA and RFA. This factor is attributed to the minute and flexible catheter of EVSA compared with the stiff glass fibers of EVLA and RFA. EVSA catheters can easily be inserted into veins without inflicting pain on the patient. Therefore, the emergence of EVSA as an alternative to EVLA and RFA will have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global endovenous ablation devices market during the forecast period 2019-2023, click here.
Competitive Landscape
With the presence of a few major players, the global endovenous ablation devices market is concentrated. robust vendor analysis is designed to help clients in improving their market positions, and in line with this, this report provides a detailed analysis of several leading endovenous ablation devices manufacturers, which include AngioDynamics Inc., Medtronic Plc, Sciton Inc., Teleflex Inc., and Venclose Inc.
Also, the endovenous ablation devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
